Optimizing Architecture of Brain Shuttle-Antisense Oligonucleotide Conjugates for the Treatment of Neurological Disorders in In Vivo Studies
Time: 11:30 am
day: Conference Day One
Details:
- Aspects and conceptual design considerations of brain shuttle-ASO conjugates
- Analyzing the translational feasibility of this system to revolutionize potentials for clinical systemic targeting of neurological disorders
- Potential of peripheral administered CNS-targeting ASOs
